Business
TRICCAR Announces $18.5 Million Private Placement Investment
TRICCAR Announces $18.5 Million Private Placement Investment.
About this update from Correlate Energy Corp.
[{"type":"text","content":"\n\n\n\nTRICCAR Announces $18.5 Million Private Placement Investment\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nTRICCAR Announces $18.5 Million Private Placement Investment\n~ Antonomastic Investment Holdings to receive 11.6 million Class A shares and seat on TRICCAR Board of Directors\nPR Newswire\nLAS VEGAS, July 13, 2020\n\n\n\n\n LAS VEGAS, July 13, 2020 /PRNewswire/ -- TRICCAR, Inc. (OTC: FOSI), a bioceutical development and marketing firm, announced that it has completed an agreement for an investment of $18,594,692 via private placement in the public entity from Antonomastic Investment Holdings, Ltd., resulting in the sale of 11,621,683 shares of common stock at $1.60 per share. As part of the investment, Nairobi, Kenya based Antonomastic Investment Holdings, Ltd. will appoint an as yet to be determined member to TRICCAR's board of directors.\n\n \n \n \n \n \n \n\n \n\"The investment by Antonomastic Investment Holdings was initially set forth in a Letter of Intent signed December 6, 2019 with TRICCAR Holdings, Inc., prior to the merger between TRICCAR Holdings and Frontier Oilfield Services,\" said Bill Townsend, President and CEO of TRICCAR, Inc. \"The delay in completing the investment was largely due to the SARS-Cov-2 pandemic. The financing round will be used for operations and international expansion of TRICCAR  products and technologies, including the general market introduction of the AVL™ antiviral formula in time for the 2020 influenza season.\"\nAs a condition of the investment, TRICCAR, Inc. will issue Class A Common Stock to Antonomastic Investment Holdings, bringing TRICCAR, Inc.'s total outstanding and issued shares to 111,621,683.\nAbout TRICCAR \nTRICCAR, Inc. is a Las Vegas, Nevada-based biomedical company, creating bioceutical solutions that support the health of those suffering from the world's most common illnesses and conditions, including, obesity, hypothyroidism, calcium deficiency, pain, diabetic neuropathy, and trigeminal neuralgia. The Company competes in markets estimated at $1 trillion in annual sales for human and...